HIFU - Gynae

• Research type

  Research Study

• Full title

  Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU): A Feasibility Study for Treating Recurrent Gynaecological Malignancies

• IRAS ID

  179624

• Contact name

  Nandita deSouza

• Contact email

  nandita.desouza@icr.ac.uk

• Sponsor organisation

  Institute of Cancer Research

• Clinicaltrials.gov Identifier

  NCT02714621

• Duration of Study in the UK

  3 years, 0 months, 1 days

• Research summary

  The primary objective of this pilot study is to determine whether or not it is feasible to use MRgHIFU to treat symptomatic (pain, bleeding) recurrent pelvic malignancy with an acceptable safety profile when conventional treatment options are not available. The ultimate goal is to be able not only to offer a viable method of symptom palliation in patients with recurrent pelvic tumours and improve their quality-of-life; but also to control tumour growth and extend life in a group of relatively young patients with isolated local recurrence.

• REC name

  West Midlands - Solihull Research Ethics Committee

• REC reference

  15/WM/0470

• Date of REC Opinion

  12 Jan 2016

• REC opinion

  Further Information Favourable Opinion